In this population-based cohort study, we observed that the APOE E2 carriers had lower mean CCA-IMT and lower odds of ≥ 4 carotid plaques than E3 homozygotes, while we found no significant association of E2 alleles with incident MI and incident stroke. This evidence concerns the gene APOE and stroke disorder.